Over the past 12 months, the application of generative AI (GenAI) in the Medical Instruments industry has moved from experimental to operational use, enhancing diagnostics, patient monitoring and intervention workflows. GenAI could transform health care through synthetic medical imaging, disease progression modeling sand drug molecule design with simulated effect, according to a 2025 U.S. National Science Foundation report. At the same time, regulatory bodies are adapting. The European Union AI Act (EU AI A ...

Tactile Systems Technology (TCMD) closed the last trading session at $26.93, gaining 1.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $38 indicates a 41.1% upside potential.The average comprises four short-term price targets ranging from a low of $32.00 to a high of $42.00, with a standard deviation of $4.32. While the lowest estimate indicates an increase of 18.8% from the cur ...

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying those that can fulfill their potential is challenging due to associated risks and volatility [1] Group 1: Company Overview - Tactile Systems Technology (TCMD) is highlighted as a recommended growth stock based on the Zacks Growth Style Score, which evaluates a company's real growth prospects beyond traditional metrics [2] - The company currently holds a favorable Growth Score and a top Zacks Rank, indicating strong investment potential [2] Group 2: Earnings Growth - Tactile Systems Technology has a historical EPS growth rate of 17.3%, but the projected EPS growth for this year is significantly higher at 38.6%, surpassing the industry average of 10.2% [5] Group 3: Asset Utilization - The company's asset utilization ratio (sales-to-total-assets ratio) stands at 1.21, indicating that it generates $1.21 in sales for every dollar in assets, which is notably higher than the industry average of 0.6 [7] Group 4: Sales Growth - Tactile Systems Technology is expected to achieve a sales growth of 9.1% this year, compared to the industry average of 7.5%, showcasing its strong sales performance [8] Group 5: Earnings Estimate Revisions - There has been a positive trend in earnings estimate revisions for Tactile Systems Technology, with the Zacks Consensus Estimate for the current year increasing by 17.6% over the past month, indicating favorable market sentiment [10]

MINNEAPOLIS, March 09, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Andrea Pearson to the Company’s Board of Directors (“Board”) and as a member of the Compliance & Reimbursement and Nominating & Corporate Governance Committees, effective March 9, 2026. Ms. Pearson is an accomplished senior executive and growth strategist with ...

Shares of Tactile Systems Technology (TCMD) have gained 3.4% over the past four weeks to close the last trading session at $29.61, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $38 indicates a potential upside of 28.3%.The mean estimate comprises four short-term price targets with a standard deviation of $4.32. While the lowest estimate of $32.00 indicates an 8.1% increase fro ...

Tactile Systems Technology Inc. (NASDAQ:TCMD) is one of the best stocks for beginners with little money in 2026. On February 17, Tactile Systems Technology delivered financial results for 2025, with total revenue rising 12% to $329.5 million. The company concluded the year with a robust cash position of $83.4 million. During this period, the company acquired Lymphotec to target the large population of undiagnosed lymphedema patients. By integrating Lymphotec’s fluid-monitoring tech into its commercial en ...

Economic Insights - Joseph Stiglitz, a Nobel Prize-winning economist, discussed the poor state of the economy and the likelihood of further deterioration, challenging optimistic views on inflation and tariffs [1] - Stiglitz emphasized that while inflation was declining post-pandemic, the decline slowed after President Trump's arrival, indicating that tariffs have a delayed effect on prices [1] Market Performance - Richard Bernstein, CEO of Richard Bernstein Advisors, noted a healthy broadening in the market since late October, attributing it to strong economic performance with nominal GDP exceeding 8% last quarter, a level not seen since 2006 [2] - Bernstein expressed surprise at the market's narrowness despite strong growth, but observed that investors are beginning to recognize the strength and breadth of corporate profits [2] Company Performance: NetScout Systems Inc. - NetScout Systems Inc. reported FQ3 2026 revenue of $250.7 million, a slight decline of 0.53% year-over-year, but exceeded Street estimates by $16.99 million, with diluted EPS increasing by 6.4% to $1.00 [7][8] - The company expects FY2026 revenue between $835 million and $870 million, with non-GAAP EPS projected between $2.37 and $2.45, driven by ~$15 million in deal pull-ins [8] - NetScout's cybersecurity segment grew by 9% over the first nine months of the year, and the company is increasingly integrating its Smart Data for AI-driven use cases [9] Company Performance: Tactile Systems Technology Inc. - Tactile Systems Technology reported a 12% increase in total revenue to $329.5 million for 2025, ending the year with a strong cash position of $83.4 million [10] - The company acquired Lymphotec to enhance patient surveillance for lymphedema patients and is investing in a new CRM system and expanded sales headcount to drive productivity [11] - Tactile issued a balanced outlook for 2026, projecting revenue growth of 8% to 11%, while acknowledging potential short-term headwinds from new Medicare prior authorization requirements [12]

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying the right ones involves navigating significant risks and volatility [1] Group 1: Company Overview - Tactile Systems Technology (TCMD) is currently highlighted as a recommended growth stock by the Zacks Growth Style Score system, which evaluates a company's genuine growth potential [2] - The company holds a favorable Growth Score and a top Zacks Rank, indicating strong investment potential [2] Group 2: Earnings Growth - Tactile Systems Technology has a historical EPS growth rate of 17.9%, but the projected EPS growth for this year is significantly higher at 38.6%, surpassing the industry average of 10.4% [4] Group 3: Asset Utilization - The company's asset utilization ratio (sales-to-total-assets ratio) is 1.21, indicating that it generates $1.21 in sales for every dollar in assets, which is notably higher than the industry average of 0.6 [6] - Tactile Systems Technology's sales are expected to grow by 9.1% this year, compared to the industry average of 8.7% [6] Group 4: Earnings Estimate Revisions - The current-year earnings estimates for Tactile Systems Technology have been revised upward, with the Zacks Consensus Estimate increasing by 17.6% over the past month, reflecting a positive trend in earnings estimate revisions [7] Group 5: Investment Positioning - Tactile Systems Technology has achieved a Zacks Rank of 2 (Buy) and a Growth Score of B, positioning it favorably for potential outperformance in the growth stock category [9]

Next-generation medical device company Tactile Systems Technology (NASDAQ: TCMD) was the very picture of health on Wednesday, at least as far as its stock was concerned. Investors bid up the company's shares robustly, by nearly 18%, thanks to an impressive earnings report. Healthy increases Just after market close on Tuesday, Tactile published its fourth quarter and full-year 2025 figures. The company's total revenue rose by a sturdy 21% to $103.6 million, and net income in accordance with generally acce ...

Tactile Systems reported fourth-quarter earnings of 46 cents, better than the consensus of 44 cents. Sales jumped 21% to $103.59 million, beating the Wall Street estimates of $93.80 million, attributable to lymphedema and airway clearance product lines.Tactile Systems forecasts fiscal 2026 sales between $357 million-$365 million compared to the consensus of $347.94 million. The company expects adjusted EBITDA in the range of $49 million to $51 million.Tactile Systems shares fell 5.3% to close at $283.46 on ...